{"version":"1.0","type":"link","title":"Author response to comment on \"Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer\".","author_name":"Kim HD 외","author_url":"https://prs-insight.online/author/Kim%20HD","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/126364","thumbnail_width":1200,"thumbnail_height":630}